Guizhen Zhao Selected Research

Vascular System Injuries

10/2021	Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling.
1/2021	Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guizhen Zhao Research Topics

Disease

9	Inflammation (Inflammations) 05/2024 - 12/2018
5	Abdominal Aortic Aneurysm 05/2024 - 01/2020
4	Atherosclerosis 10/2023 - 01/2021
4	Neoplasms (Cancer) 01/2023 - 01/2021
2	Neointima 10/2021 - 01/2018
2	Vascular System Injuries 10/2021 - 01/2021
2	Aneurysm (Aneurysms) 01/2021 - 01/2020
2	Rupture 01/2020 - 12/2018
2	Thoracic Aortic Aneurysm 01/2019 - 12/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2018 - 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Wound Infection (Wound Infections) 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022
1	Hypercholesterolemia 10/2021
1	Hyperthermia 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Fatty Liver 12/2020
1	Hyperlipidemias (Hyperlipidemia) 12/2020
1	Non-alcoholic Fatty Liver Disease 12/2020
1	Obesity 01/2018
1	Adenoviridae Infections (Adenovirus Infections) 01/2018
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2017
1	Persistent Infection 09/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2002
4	CytokinesIBA 10/2021 - 12/2020
3	Pancreatic Elastase (Elastase)IBA 11/2022 - 10/2020
3	Angiotensin IIIBA 10/2021 - 12/2017
2	ElastinIBA 05/2024 - 10/2020
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021 - 12/2020
2	Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA 01/2021 - 12/2020
2	Extracellular Matrix ProteinsIBA 01/2021 - 12/2018
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2020
2	ApolipoproteinsIBA 01/2021 - 12/2017
2	Apolipoproteins E (ApoE)IBA 01/2021 - 12/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 12/2020
2	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 01/2019 - 12/2018
1	Adenosine KinaseIBA 05/2024
1	S-Adenosylmethionine (Ademetionine)IBA 05/2024
1	histone H3 trimethyl Lys4IBA 05/2024
1	ABT 702IBA 05/2024
1	RNA (Ribonucleic Acid)IBA 01/2023
1	nasIBA 01/2023
1	CopperIBA 01/2023
1	GoldIBA 01/2023
1	Serum Response FactorIBA 11/2022
1	ChromatinIBA 11/2022
1	Thromboplastin (Tissue Factor)IBA 05/2022
1	Glycoproteins (Glycoprotein)IBA 10/2021
1	nidogen (entactin)IBA 10/2021
1	PPAR gammaIBA 10/2021
1	CXA-10IBA 10/2021
1	Cartilage Oligomeric Matrix ProteinIBA 01/2021
1	NanogelsIBA 01/2021
1	ChemokinesIBA 01/2021
1	HydrogelsIBA 01/2021
1	OxalatesIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	IronIBA 01/2021
1	Superoxides (Superoxide)IBA 01/2021
1	LipidsIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	FructoseIBA 12/2020
1	CholesterolIBA 12/2020
1	Transaminases (Aminotransferases)IBA 12/2020
1	Glutathione (Reduced Glutathione)IBA 12/2020
1	CyclodextrinsIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	ThrombospondinsIBA 12/2018
1	Metalloproteases (Metalloproteinases)IBA 12/2018
1	AminopropionitrileIBA 12/2018
1	DisintegrinsIBA 12/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2018
1	AdipokinesIBA 01/2018
1	calcium phosphateIBA 12/2017

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2020
2	Immunotherapy 01/2023 - 01/2021
2	Intravenous Injections 01/2021 - 01/2021
1	Rejuvenation 10/2023
1	Drug Therapy (Chemotherapy) 01/2021